AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 238: E409-E415, 1980;
0193-1849/80 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoppel, C. L.
Right arrow Articles by Genuth, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoppel, C. L.
Right arrow Articles by Genuth, S. M.

AJP - Endocrinology and Metabolism, Vol 238, Issue 5 409-E415, Copyright © 1980 by American Physiological Society


ARTICLES

Carnitine metabolism in normal-weight and obese human subjects during fasting

C. L. Hoppel and S. M. Genuth

Carnitine metabolism was studied in normal-weight and obese subjects by measurement of carnitine and its acyl derivatives in plasma and urine. When first fed an isocaloric, low-carnitine diet, both groups showed a decrease in plasma total carnitine, primarily due to a decrease in the free carnitine fraction. Urinary free carnitine excretion also fell significantly. When fasting was instituted, plasma total carnitine concentration increased. This was the net result of a rapid increase in short-chain and long-chain acylcarnitine and a delayed decrease in free carnitine. Urinary excretion of short-chain acylcarnitines increased parallel to rising plasma concentrations, whereas free carnitine excretion first decreased and then tended to increase slightly. Both plasma and urinary short-chain acylcarnitine correlated with beta-hydroxybutyrate. All of these changes were reversed by refeeding, in the obese even with a low-carnitine hypocaloric intake. Obese subjects also developed hyperketonemia significantly more slowly than did normal-weight subjects, yet demonstrated substantially the same changes in magnitude and direction in carnitine and its metabolites.


This article has been cited by other articles:


Home page
J. Nutr.Home page
G. Blanchard, B. M Paragon, F. Milliat, and C. Lutton
Dietary L-Carnitine Supplementation in Obese Cats Alters Carnitine Metabolism and Decreases Ketosis during Fasting and Induced Hepatic Lipidosis
J. Nutr., February 1, 2002; 132(2): 204 - 210.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Brevetti, F. di Lisa, S. Perna, R. Menabo, R. Barbato, V. Domenico Martone, and N. Siliprandi
Carnitine-Related Alterations in Patients With Intermittent Claudication : Indication for a Focused Carnitine Therapy
Circulation, May 1, 1996; 93(9): 1685 - 1689.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online